THCB

Categories

Tag: Bayer G4A Signing Day

From Ophthalmology Clinic to At-Home Device: Disrupting OTC Testing | Helge Sudkamp, Visotec

By JESSICA DaMASSA, WTF HEALTH

Optical coherence tomography, otherwise known as OCT testing, gives eye doctors a glimpse of the retina to help detect eye diseases like glaucoma, macular degeneration, retinopathy, and more. So, what’s wrong with current methods of testing? Helge Sudkamp, CEO & co-founder of Visotec, explains how traditional OCT machines are huge, bulky and expensive — limiting scanning to infrequent visits at the doctor’s office. His company has a new take on OCT tech that puts the scanning into patients’ hands with a small, portable device that can be used daily AT HOME. What can daily at-home monitoring offer eye patients and their doctors? Never-before-collected data on the day-to-day progress of eye disease for one. Find out more about how Visotec ultimately hopes to leverage this new info to build algorithms into their devices that will be able to detect biomarkers that help identify eye diseases faster.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Disrupting How We Detect Asthma & Hypertension | Edward Allegra, BioLum Sciences

BY JESSICA DAMASSA

BioLum Sciences is introducing new chemistry that has the potential to completely change the way we test for respiratory illnesses, like asthma, and analyze blood samples to identify hypertension. CEO Edward Allegra talks through the science behind both their breath and blood tests, both of which are patent-pending and have the ability to completely bend the cost-curve when it comes to identifying and monitoring these two common chronic conditions. What’s next for the early-stage health startup? A range of applications to detect everything from COPD to lung cancer and more.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Detecting Heart Conditions Faster: The Case for Biomarkers-PLUS-AI | Dean Loizou, Prevencio

BY JESSICA DAMASSA

Can artificial intelligence help prevent cardiovascular diseases? Biotech startup, Prevencio, has developed a proprietary panel of biomarkers that uses blood proteins and sophisticated AI algorithms to detect cardiovascular conditions like coronary and peripheral artery disease, aerotic stenosis, risk for stroke and more. Dean Loizou, Prevencio’s VP of Business Development, breaks down the process step-by-step and explains exactly how Prevencio reports its clinically viable scores to doctors. How does the AI fit into all this? We get to that too, plus the details around this startup’s plans for raising a B-round on the heels of this work with Bayer.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Digital Therapeutic for Chronic Condition Management in India | Abhishek Shah, Wellthy Therapeutics

• 1

BY JESSICA DAMASSSA, WTF HEALTH

As the adage goes, “health is wealth,” and Wellthy Therapeutics is a startup looking to improve the health of patients with chronic conditions in India by making treatment more accessible. Only 5% of Indians are insured and much of the population is not health literate, so CEO Abhishek Shah hopes the Wellthy app will fill a critical gap in care for those with type II diabetes, hypertension, cardiovascular conditions, and respiratory illnesses. With 15K users, the startup is focused on scaling up to truly capitalize on the potential of India’s enormous population. Learn more about their big plans, including those for a Series-A, to support that expansion.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Continue reading…

Radiology Gets an “App Store” for its AI Tools | Ben Panter, Blackford Analysis

AI in radiology is not new. In fact, the field is swarming with various apps and tools seeking to find a place in the radiologist’s toolkit to get more value out of medical imaging and improve patient care. So, how does a radiology team pick which tools to invest in? Enter Blackford Analysis, a health tech startup that has, simply put, designed an “app store” for radiology departments that liberates access to life-saving tech for radiologists. CEO Ben Panter explains how the platform not only gives radiologists access to a curated group of best-in-class AI radiology tools, but does so en-mass to circumvent the need for one-off approvals from hospital administrators and procurement teams.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Continue reading…

Disrupting Healthcare Payment with Mobile Platform M-TIBA | Maarten Ras, CarePay

BY JESSICA DAMASSA, WTF HEALTH

What’s the future of healthcare payment? Could it be mobile?? CarePay is a health tech startup that is revolutionizing the way people in Africa send, save and spend funds for medical treatments via their mobile app M-TIBA. Maarten Ras, Regional Commercial Director shares how M-TIBA digitizes healthcare insurance schemes for the Kenyan government, allowing patients access to their healthcare benefits — and a way to pay for medical services — from their phone. A dream-scenario for health systems around the world that are looking for versatility, transparency and accountability in payment management, but is it really scalable? We find out who’s using M-TIBA right now, and how far CarePay is trying to go. Surely, a startup working so closely with national governments (including one that enrolled 2.5 million people just four months ago) is bound for big things?

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Continue reading…

A Clinically Validated Game Teaching Mental Health Coping Strategies | Swatee Surve, Litesprite

By JESSICA DAMASSA, WTF HEALTH

How can helping a cartoon fox also help your mental health? Enter Socks the Fox and Sinasprite, a world exploration game that teaches players evidence-based treatments and coping methods for anxiety and depression. How does it work? Litesprite CEO Swatee Surve explains that players are charged with helping Socks the Fox become a Zen master (of course) and, in doing so, work through a series of challenges and exercises that teach coping mechanisms that range from journaling to diaphragmatic breathing. With its super-sticky storyline (Socks is adorable) the clinically validated game offers a new, upbeat way to bring tech and game theory into the way we treat mental health disorders.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

This Video Game App is Really Remote Monitoring for Eye Diseases | Stephanie Campbell, OKKO Health

By JESSICA DAMASSA, WTF HEALTH

Keep your eyes peeled for OKKO Health, the startup that has created an AI-driven app game to make sure that your eyes are healthy. Founder-and-optometrist Stephanie Campbell explains how the game works to help clinicians to remotely monitor patients with eye diseases that would otherwise require frequent hospital visits to manage; think diabetic eye disease or age-related macular degeneration. Can we really look to gaming as a way for remote patient monitoring? OKKO certainly sees it that way!

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Continue reading…

Glen Tullman’s Advice for Health Startups | Glen Tullman, Livongo

By JESSICA DAMASSA, WTF HEALTH

A must-watch for any startup looking to make it big in the digital health world. Glen Tullman, Chairman of Livongo, shares his best advice for new and emerging startups seeking to disrupt healthcare. On the heels of his company’s IPO, and just after closing the company’s biggest contract to-date with the US Federal Government, Glen talks closing deals, building a great team, what it’s like to navigate the contracting process with a big org like the US government, and more. Entrepreneurial spirit abounds at the Bayer G4A Signing Day event in Europe. Does that mean that Livongo will be jumping into the European market any time soon? Tune in to find out!

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.

Continue reading…

This Digital Health Tool is Proven to Improve Cognitive Fitness | Jean Castonguay, NeuroTracker

• 1

By JESSICA DAMASSA, WTF HEALTH

Neuroscience startup, NeuroTracker, has a virtual training tool with a proven ability to help improve “cognitive fitness.” Jean Castonguay, co-founder, board member and Head of Global Strategic Partnerships at NeuroTracker, explains the science and clinical validation behind their tech and drops some big name users in the process — Manchester United, German and French soccer teams, US special forces, as well as some of the world’s leading sports concussion rehabilitation clinics. What sets the startup apart from other companies in the mental performance space? How have they shored up their science in the face of Lumosity’s Federal Trade Commission suit against false claims about brain health outcomes? It shook up the industry, and NeuroTracker actually feels it strengthened their business and their value proposition.

Filmed at Bayer G4A Signing Day in Berlin, Germany, October 2019.